Trial watch: hepatitis E vaccine confers complete protection in phase III trial.
D000293:Adolescent; D000328:Adult; D000368:Aged; D017326:Clinical Trials, Phase III as Topic / Q000379:methods / Q000639:trends; D005260:Female; D016751:Hepatitis E / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D016752:Hepatitis E virus / Q000254:growth & development / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*; D055815:Young Adult
D014761:Viral Hepatitis Vaccines